Main Image

About Angioimmunoblastic T-Cell Lymphoma

What is Angioimmunoblastic T-Cell Lymphoma?

Angioimmunoblastic T-Cell Lymphoma (AITL) is a rare type of non-Hodgkin lymphoma (NHL) that affects the T-cells of the immune system. It is characterized by the presence of abnormal T-cells in the blood and lymph nodes, as well as an increase in the number of other immune cells, such as B-cells and macrophages. Symptoms of AITL include fever, night sweats, weight loss, and enlarged lymph nodes. Treatment typically involves chemotherapy and/or radiation therapy.

What are the causes of Angioimmunoblastic T-Cell Lymphoma?

The exact cause of angioimmunoblastic T-cell lymphoma (AITL) is unknown. However, some research suggests that certain genetic mutations, viruses, and environmental factors may play a role in its development. Additionally, some studies have suggested that certain medications, such as immunosuppressants, may increase the risk of developing AITL.

What are the treatments for Angioimmunoblastic T-Cell Lymphoma?

The main treatments for Angioimmunoblastic T-Cell Lymphoma (AITL) are chemotherapy, radiation therapy, and stem cell transplant. Chemotherapy is the most common treatment and may include drugs such as cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab. Radiation therapy may be used to target specific areas of the body affected by the lymphoma. Stem cell transplant may be used in some cases to replace damaged cells with healthy ones. Other treatments may include targeted therapy, immunotherapy, and monoclonal antibody therapy.

What are the risk factors for Angioimmunoblastic T-Cell Lymphoma?

1. Age: Angioimmunoblastic T-Cell Lymphoma (AITL) is more common in people over the age of 60.

2. Gender: AITL is more common in men than in women.

3. Immunosuppression: People with weakened immune systems, such as those with HIV/AIDS or those taking immunosuppressive medications, are at an increased risk of developing AITL.

4. Infections: People with certain infections, such as Epstein-Barr virus (EBV) or hepatitis C virus (HCV), may be at an increased risk of developing AITL.

5. Family history: AITL may be more common in people with a family history of lymphoma.

Is there a cure/medications for Angioimmunoblastic T-Cell Lymphoma?

Yes, there are treatments available for Angioimmunoblastic T-Cell Lymphoma. Treatment options may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Your doctor will determine the best treatment plan for you based on your individual situation.